Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 01, 2022	Jun. 25, 2021
Cash flows from operating activities:
Net loss	$ (3,600)	$ (7,092)
Adjustments to reconcile net loss to net cash from operating activities:
Depreciation and amortization	29,855	27,910
Amortization of debt issuance costs	921	3,051
Deferred income taxes	(6,462)	408
Loss on sale and disposal of property and equipment	81	205
Equity-based compensation	12,367	2,238
Non-cash operating lease expense	6,298	0
Bad debt expense	100	180
Fair value adjustment to contingent value rights	(6,075)	2,840
Provision for credit losses on notes receivable	5,872	0
Change in operating assets and liabilities:
Accounts receivable	(4,851)	(6,313)
Inventories	(58,262)	(15,234)
Prepaid expenses and other assets	5,273	(6,481)
Accounts payable, accrued liabilities and operating lease liabilities	(1,070)	(6,327)
Net cash used in operating activities	(19,553)	(4,615)
Cash flows from investing activities:
Acquisition of business, net of cash acquired	(25,639)	(25,821)
Purchases of property and equipment	(6,414)	(4,413)
Issuance of notes receivable	(600)	0
Other	45	(429)
Net cash used in investing activities	(32,608)	(30,663)
Cash flows from financing activities:
Payments on long-term debt	(1,163)	(3,595)
Proceeds from revolving credit facility	47,000	0
Repurchase and retirement of common stock	(918)	0
Payment of deferred initial public offering costs	0	(2,730)
Net cash provided by (used in) financing activities	44,919	(6,325)
Effect of exchange rate changes on cash and cash equivalents	(2,017)	(5)
Net decrease in cash and cash equivalents	(9,259)	(41,608)
Cash and cash equivalents at beginning of the period	40,577	77,458
Cash and cash equivalents at end of the period	31,318	35,850
Supplementary cash flow information:
Cash paid for interest	14,657	16,083
Cash paid for taxes, net	3,445	743
Noncash investing and financing activities:
Noncash equity contribution	0	10,025
Capital expenditure in accounts payable	$ 321	$ 251